Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Edwards Lifesciences Corp., consolidated statement of comprehensive income

US$ in thousands

12 months ended:	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net income	1,503,100)	823,400)	1,046,900)	722,200)	583,600)
Foreign currency translation adjustments	(50,100)	32,400)	(11,200)	(38,600)	97,500)
Unrealized gain (loss) on hedges	57,400)	(40,200)	(11,100)	40,400)	(30,600)
Unrealized pension credits (costs)	11,600)	(4,200)	(1,900)	600)	3,500)
Unrealized gain (loss) on available-for-sale investments	(24,100)	6,600)	6,300)	(3,300)	(7,800)
Reclassification of net realized investment loss to earnings	8,600)	300)	400)	2,900)	3,100)
Other comprehensive income (loss), net of tax	3,400)	(5,100)	(17,500)	2,000)	65,700)
Comprehensive income	1,506,500)	818,300)	1,029,400)	724,200)	649,300)

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Download chart

Comprehensive income item	Description	The company
Net income	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Edwards Lifesciences Corp. net income decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.
Comprehensive income	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners.	Edwards Lifesciences Corp. comprehensive income decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.

Edwards Lifesciences Corp. (NYSE:EW)

Statement of Comprehensive Income